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Abstract
Background: Many people with mental illness do not seek or delay seeking care. This study aimed to develop, and
provide an initial validation of, a comprehensive measure for assessing barriers to access to mental health care
including a ‘treatment stigma’ subscale, and to present preliminary evidence about the prevalence of barriers
experienced by adults currently or recently using secondary mental health services in the UK.
Methods: The Barriers to Access to Care Evaluation scale (BACE) was developed from items in existing scales,
systematic item reduction, and feedback from an expert group. It was completed in an online survey by 117
individuals aged 18 and over who had received care from secondary mental health services in the past 12 months.
Internal consistency, test-retest reliability, convergent validity (correlation of treatment stigma subscale with the
Stigma Scale for Receiving Psychological Help (SSRPH) and with the Internalised Stigma of Mental Illness Scale
(ISMI)), respondent opinion and readability were assessed.
Results: The BACE items were found to have acceptable test-retest reliability as all but one of the items exceeded the
criterion for moderate agreement. The treatment stigma subscale had acceptable test-retest-reliability and good
internal consistency. As hypothesised the subscale was significantly positively correlated with the SSRPH and the ISMI
demonstrating convergent validity. The developmental process ensured content validity. Respondents gave the BACE a
median rating of 8 on the 10-point quality scale. Readability scores indicated the measure can be understood by the
average 11 to 12 year-old. The most highly endorsed barrier was ‘concern that it might harm my chances when
applying for jobs’. The scale was finalised into a 30-item measure with a 12-item treatment stigma subscale.
Conclusions: There is preliminary evidence demonstrating the reliability, validity and acceptability of the BACE. It can
be used to ascertain key barriers to access to mental health care which may help to identify potential interventions to
increase care seeking and service use. Further research is needed to establish its factor analytic structure and
population norms.
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Background
Avoidance of mental health care
A large proportion of people with mental illness do not re-
ceive care [1]. In Europe 27% of people experience mental
illness (all disorders) each year, but 74% receive no treat-
ment [2]. For mood, anxiety and substance use disorders
severe enough to significantly interfere with everyday life,
only 48% received any formal healthcare [3]. The figures
for individuals with the same disorders in the USA are
31% with the mental disorders and 67% not treated [4].
In these countries much of the treatment gap can be
accounted for by people not seeking or delaying seeking
mental health care. In low and middle income countries
there are even greater levels of undertreatment [5] due to
both avoidance of health care and lack of care provision.
Not seeking health care, or delayed care-seeking, may re-
sult in there being a longer period of untreated illness and,
for psychotic illness, this is associated with worse out-
comes such as having more symptoms, poorer functioning
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It may also contribute to adverse pathways to care such as
the involvement of the criminal justice system and invol-
untary admissions under mental health legislation [7].
When individuals do seek or receive care they may subse-
quently drop out of services or may have low levels of
engagement with services such as missing appointments
or not seeking care in a crisis [8]. Therefore health care-
seeking can be conceptualised as a process not restricted
to the period before first contact with services. Whilst
mental illness sometimes remits without professional
care, avoidance of health care at any stage in this process
may result in an individual not receiving effective treat-
ments, which may contribute to the continuation of ill-
ness and the negative impacts that illness can bring,
although this is not always so, particularly for less severe
conditions.
The reasons why people with mental ill health some-
times avoid or delay seeking help from health services
are numerous and include instrumental barriers such as
not knowing where to go for help, or financial barriers,
or they may be attitudinal such as perceived lack of ef-
fectiveness of treatments offered, thinking the problem
will resolve itself, preferring to solve the problem on one’s
own, and fear of being hospitalised against one’sw i l l
[9,10]. One reason that has received increasing research
attention is the potential for stigma and discrimination
to act as barriers to access to health care-seeking. Four
reviews have examined the impact of stigma on access to
mental health care and each concluded that it had a sig-
nificant detrimental effect [11-14]. Prospective studies pro-
vide evidence that stigma may have a negative impact on
service use [15,16]. Thus it is clear that both non-stigma-
related (instrumental / attitudinal) and stigma-related bar-
riers limit access to mental health care, but what is not
currently known is the relative influence of these different
types of barriers.
Measuring mental health care-seeking
In the context of an ongoing systematic review on the
association between stigma and health care we identified
the following types of measure that have been used to
assess mental health care seeking: previous / current ac-
tual service use; intention to seek health care; attitudes to
health care seeking; recommendations regarding health
care seeking for a vignette character; and barriers-based
measures in which respondents are presented with a list of
potential barriers and are asked whether, or not or to what
extent, each has been a barrier for them. The advantage of
barriers-based measures is that they indicate what pre-
vents or delays individuals from health care-seeking and
so may inform interventions to increase health care seek-
ing and service use. We identified 23 studies that had
assessed barriers to mental health care seeking [9,17-38].
A limitation of the existing barriers-based measures
was that they did not always provide a comprehensive
list of barriers. This was particularly true for stigma where
measures sometimes simply referred to stigma as a bar-
rier rather than enquiring about particular components
of stigma (e.g. embarrassment / shame, concern about
others’ disapproval, disclosure concerns, desire to avoid
a stigma stereotype, and anticipated discrimination).
Additionally the measures often had dichotomous re-
sponse categories, when barriers are often experienced
to a lesser or greater extent. Existing measures rarely
encompassed service avoidance post-first contact. A final
limitation is that few of the existing measures produced
composite scores even though such scoring may be con-
ceptually meaningful for some types of barrier e.g. stigma-
related barriers.
Measuring ‘treatment stigma’
‘Treatment stigma’ refers to the stigma and discrimin-
ation that individuals believe to be associated with re-
ceiving care for a mental health problem. We identified
nine treatment stigma scales or subscales [27,39-46]
from our on-going systematic review. The measures were
in the main Likert attitude scales (measures with state-
ments followed by ‘strongly agree’,‘agree’ etc.). Only three
measures were barriers-based [40,43,45]. A strength of a
barriers-based measure of treatment stigma is that it is
more tied to behaviour than attitudinal measures and
permits the influence of stigma-related barriers to be
compared to that of other types of barriers. However the
existing barriers-based measures of treatment stigma
cannot readily be used with general mental health popu-
lations as one is for adolescents [40], one has been used
predominantly in military settings [43] and one mainly
in the context of psychotherapy [45]. Furthermore there
is no existing measure of treatment stigma which is applic-
able to all mental health conditions, all types of mental
health care and all types of stigma. For example, some
measures focus solely on specific conditions such as de-
pression [27,44,46]; some refer solely to psychological help
[41-43,45] and some to care from a psychiatrist [46]. Some
measures exclusively assess the internalised stigma asso-
ciated with receiving mental health care [42,44]; one fo-
cuses on the public stigma associated with psychological
care for mental ill health [41], and one measures antici-
pated discrimination [46].
Need for a new measure
We conclude from the overview of existing research and
issues discussed above that there is a need for a compre-
hensive measure of barriers to access to professional
care for mental ill health that has nominal rather than
categorical response categories. In addition there is a
currently unmet need for a barriers-based measure of
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with any type of mental health problem, regarding any
type of professional care, and covering all types of treat-
ment stigma. We believe that a measure that encom-
passes health-care-seeking post- and well as pre- first
receipt of care is needed to better reflect the fact that
care-seeking is a process. The measure described here
meets these three sets of requirements within one measure.
Aims
This study aimed to:
1) develop a comprehensive self-complete measure -
the Barriers to Access to Care Evaluation (BACE) -
for assessing barriers to care-seeking for mental ill
health, encompassing care avoidance post- as well as
pre-contact with services;
2) develop from a subset of the BACE items a subscale
for assessing the stigma associated with receiving
mental health care (treatment stigma);
3) establish the psychometric properties of the BACE
and its treatment stigma subscale;
4) present preliminary evidence about the prevalence of
stigma-related and non-stigma-related barriers to
care-seeking for mental ill health reported by a
sample of adults recently or currently using
secondary mental health services.
Methods
Design
The design is a four-stage psychometric validation study.
Stage one involved the collation and reduction of bar-
riers items from the existing literature and the creation
of a draft measure. In stage two an expert panel revised
the measure. Stage three was a cross-sectional survey
repeated for test-retest reliability. This was embedded
within a survey whose primary purpose was to develop
another scale, the Questionnaire on Anticipated Discrim-
ination (QUAD). Stage four was the finalisation of the
measure based on psychometric findings from the survey.
Sample and recruitment
As the BACE is intended for completion by individuals
at any stage in the health care seeking process including
those who have not and who have already received men-
tal health care, we made a pragmatic decision to use the
latter type of sample, taking the opportunity to include
the preliminary BACE scale in the QUAD study. Inclu-
sion criteria for the QUAD study, and consequently also
the present study, were: 1) Having received care from
secondary mental health services in the 12 months or
currently; 2) aged 18 or over; and 3) access to the internet
as the survey was to be completed online. Participants
were recruited through the following routes: emails to
members who participated in a previous phase of the
QUAD development study in our research programme (all
living in South-East England); and advertisements on web-
sites and social networks (Facebook, Twitter) of England’s
national anti-discrimination programme (Time to Change)
and of two national UK mental health charities (Rethink,
Mental Health Foundation). The target sample size was
100 (with 50 completing the survey a second time for as-
sess test-retest reliability) and was based on the numbers
required to perform the analyses needed for the psycho-
metric validation of the QUAD.
Ethics
The QUAD study and an amendment permitting the
inclusion of the BACE v2, and the Stigma Scale for Seek-
ing Psychological Help [41] were approved by the King’s
College London Psychiatry, Nursing and Midwifery Re-
search Ethics Sub-Committee (ref: PNM/09/10-103).
Procedure
The BACE scale was developed through an iterative
process. In stage one, one author (SC) collated barriers
items from the 23 barriers studies [9,17-38] that we identi-
fied in our on-going systematic review on the association
between stigma and health care seeking. These studies
included samples of individuals with a variety of mental
health problems and sociodemographic characteristics,
who had and had not previously accessed care for mental
health problems, as well as some general population stud-
ies. This initial method of sourcing items was chosen to
capitalise on the large body of existing work in this area
and to avoid duplication of effort. Items that were identical
to other items, not relevant to a general population, am-
biguous or rarely endorsed in the studies reporting them
were then excluded from the item pool. When items used
different words to refer to the same barrier, one item was
selected, or the items were rephrased into a single new
item. The research team then added items not yet covered
that were known to be important in the qualitative and
theoretical research literature on health care seeking. This
set constituted the items for the BACE v1. The research
team devised a root question: ‘Have any of these issues
ever stopped, delayed or discouraged you from getting, or
continuing with, professional care for a mental health
problem?’. Professional care was defined as ‘care from such
staff as a GP (family doctor), community mental health
team (e.g. care coordinator, mental health nurse or mental
health social worker), psychiatrist, counsellor, psychologist
or psychotherapist’. The response categories were ‘This
has stopped, delayed or discouraged me not at all / a little /
quite a lot / a lot’.
In stage two BACE v1 was sent to an expert panel for
comment. The panel comprised three people with ex-
perience of mental illness (various diagnoses, all with
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care), three social scientists working in the field of stigma
and / or help-seeking, three clinicians (two psychiatrists and
a mental health nurse) and a lay person with no post-16
education to check for clarity and ease of understanding.
The feedback was used to delete, add and rephrase items to
create the BACE v2. Each item was designated by the re-
search team, on a conceptual basis, as being either a stigma-
related or non-stigma-related barrier to care seeking.
In stage three participants completed the BACE v2 and
other measures in an anonymised online survey. Partici-
pants were invited to recomplete the BACE v2 two
weeks later, also online. The fourth stage of scale devel-
opment was to modify the BACE v2 on the basis of the
psychometric findings and further discussion within the
research team into the BACE v3.
Measures
Three measures relevant to this study were included in
the survey: (i) the Barriers to Access to Care Evaluation
(BACE v2); (ii) the Stigma Scale for Receiving Psycho-
logical Help (SSRPH) [41]; and (iii) the Internalised Stigma
of Mental Illness (ISMI) [47]. The latter two were used for
assessing the convergent validity of the BACE. The Bar-
riers to Access to Care Evaluation (BACE v2) is a 36-item
measure scored from 0 (not at all) to 3 (a lot) with higher
scores indicating a greater barrier. The BACE treatment
stigma subscale score is the mean of stigma-related barriers
ratings. It ends with space for free text entries describing
two other barriers participants may have experienced. The
Stigma Scale for Receiving Psychological Help (SSRPH)
[41] is a 5-item measure of treatment stigma focusing
predominantly on social stigma. Golberstein’s [48] adapted
version referring to any type of mental health treatment
was used. It has four response categories from strongly
disagree to strongly agree, with a high scores indicating
greater treatment stigma. Its internal consistency is
alpha=0.72 [41]. The Internalised Stigma of Mental Illness
(ISMI) scale is a 29-item measure that assesses mental
health service users’ experience of internalised stigma [47].
It has four response categories from strongly disagree to
strongly agree and high scores indicate high internalised
stigma. It has strong internal consistency (α=0.90) and
test–retest reliability (r=0.92) [47]. In addition participants
were asked ‘Please choose one number between 1 (very
poor) and 10 (very good) to show your overall opinion of
the BACE questionnaire?’ and to add free text comments
about the measure. There were further items on sociode-
mographic and illness characteristics.
Analysis
Data were analysed using SPSS v15 [49] and Stata v10.1
[50]. There were no missing data as the online survey
was set to preclude this.
Reliability
To assess the test-retest reliability of individual items
weighted intra-class correlation co-efficients were calcu-
lated with kappa’s above 0.4 indicating moderate agree-
ment [51] as the criterion for acceptable reliability. Lin’s
concordance statistic (ρc) was used to calculate the over-
all test-retest reliability for the treatment stigma subscale
[52], with a criterion of Lin’s ρc >0.70 used to indicate
acceptable reliability. The internal consistency of the
treatment stigma subscale was assessed using Cronbach’s
alpha, with a value above 0.7 but not higher than 0.9
taken to indicate good internal consistency [53].
Validity
Content validity is the extent to which a measure com-
prehensively covers domains of interest [54] and was
assured by the development of the measure having incor-
porated the extant literature, and the perspectives of
people with mental illness and professional experts. A
further indication of this type of validity was provided by
content analysis of free text answers about other barriers.
Construct validity was assessed by examining convergent
validity [55], hypothesising that the treatment stigma
subscale would be significantly positively correlated with
both the SSRPH and the ISMI.
Acceptability
Two aspects of the acceptability of the measure were
considered: respondent opinion and readability. Descrip-
tive statistics on respondents’ overall ratings of the
BACE.v2 were calculated. The readability of the BACE
v3 was assessed using the Flesch Reading Ease score and
Flesch-Kincaid Grade level functions within Microsoft
Word which assess readability based on the syllabic and
sentence structure of the text [56]. Scores for the former
range from 0–100 with higher scores meaning easier to
read and scores of 60-70 representing acceptable scores
for documents for general adult populations. The latter
provides the US educational grade to which the material
is most appropriate [56].
Finalising the BACE v2 into the BACE v3
Items which were endorsed as a major barrier by less
than 10% of the sample were considered for removal as
were items that were very highly correlated with other
items (Spearman’s rho>0.7) and those with poor or
slight test-retest agreement (Kappa≤0.2 [57]. Conceptual
and wording issues were also further considered at this
stage and amendments made.
Prevalence of stigma-related and non-stigma-related
barriers
Percentages endorsing each item as a barrier (to any de-
gree) or as a major barrier (rated as ‘al o t ’) were calculated
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percentage rating them as a major barrier to show the rela-
tive prevalence of stigma-related and non-stigma-related
barriers.
Results
Participants
117 individuals completed the survey, and 59 of these
participants recompleted the BACE to provide test-retest
reliability data. Those providing the test-retest data did
not differ significantly from the remainder of the sample
in age, gender, ethnicity, education, employment status,
age at first treatment, and hospital admittance for psy-
chiatric treatment, although those with non-psychotic
conditions were more likely to be in the retest sample
(66% vs 34%,
2=5.062, p=0.024) compared to those with
psychotic conditions. The characteristics of the sample
are shown in Table 1. Participants had a mean age of 36
(range 18 to 70), 80% were female, the majority (87%)
reported their ethnicity as White British, and 42% were
in full- or part-time employment. The most common
self-reported primary diagnoses were depression (34%)
and bipolar disorder (31%). Forty six percent had been
hospitalised for a mental health problem.
Development of the BACE v1 and v2
There were 172 barriers items in the 23 papers assessing
barriers. This was reduced to 30 items following deletion
and amalgamation by the research team. The team iden-
tified eight additional items from their knowledge of the
research literature. Consequently the BACE v1, sent to
the expert panel, had 38 items. Four of these items were
deleted following feedback from the panel because they
were viewed as ambiguous or already covered by a simi-
lar item. Two new items (20 and 21 in Table 2) were
added at the expert panel’s suggestion making the BACE
v2 a 36 item measure. Minor rewording was made in five
items (revised items 3, 12, 16, 24 and 34 in Table 2), and
two items were reworded for conceptual reasons (revised
items 9 and 11 in Table 2). The research team designated
13 of the BACE v2 items as stigma-related, 23 as non-
stigma related barriers, as shown in Table 2. One item
(‘Difficulty taking time off work’) was viewed as poten-
tially both instrumental and stigma-related because it
risked disclosing the mental illness. A further two items
(‘Concerns about the confidentiality of the information I
share’ and ‘Dislike of talking about my feelings, emotions
or thoughts’) were viewed as potentially both attitudinal
and stigma-related. A decision was made to only desig-
nate items stigma-related if when there was no alternative
potential designation for the barrier. The items that were
designated stigma-related spanned anticipated discrimin-
ation in employment (items 6 and 33 in Table 2) and in
relation to parenting (item 29), social stigma (items 9, 16
and 31), disclosure concerns (items 19 and 25), stereo-
types (items 3, 14 and 21), internalised stigma (item 11)
and stigma by association (item 26).
Distribution of the BACE treatment stigma subscale
BACE treatment stigma scores varied from 0 to 3 with a
mean of 1.43 (sd 0.73). The BACE treatment stigma scale
was normally distributed (Kolmogrov-Smirnov Z=0.86,
p=0.454), therefore parametric statistics are appropriate
for use with this scale.
Reliability
The majority (22/36) of the BACE v2 items had weighted
kappa values from 0.61 to 0.80 indicating substantial
agreement between test and retest [51]; two items (12
and 29 of the BACE v2 shown in Table 2) had values
above 0.8 indicating almost perfect agreement; 11 items
had values between 0.41 and 0.60 indicating moderate
agreement, and one (item 3, ‘Concern about being seen
as weak for having a mental health problem’) had a kappa
of 0.346 meaning fair reliability, but not reaching the pre-
specified criterion of 0.4. Lin’s concordance statistic for
the treatment stigma subscale was ρc=0.816 exceeding
the criterion of 0.70 for acceptable test-retest reliability.
The Cronbach’s alpha value for the treatment stigma sub-
scale was 0.89 indicating good internal consistency.
Validity
Twenty two participants gave free text answers in re-
sponse to questions about other barriers. Content ana-
lysis the 36 additional barriers revealed 20 were already
covered by the existing items, and 10 were proposed by
one respondent only, thereby indicating good content
validity. Provider delay and providers not responding to
requests for help were mentioned as a barrier by four
people, which suggests this is an aspect for further study.
The hypothesised significant positive correlation between
the BACE treatment stigma subscale and the SSRPH
[41] was supported (r=0.30, p=0.001), as was the same
hypothesised relationship between the BACE treatment
stigma subscale and the Internalised Stigma of Mental
Illness Scale [47] (r=0.40, p<0.001). Thus the subscale
has convergent and hence construct validity.
Acceptability
Respondents gave a median overall evaluation rating of
the BACE of 8 (IQR 7-9) on the 10-point scale, indicat-
ing a positive respondent opinion of the measure. The
Flesch Reading Ease score for the BACE v3 was 78.8, in-
dicating it is easier to read than documents at the gen-
eral population level of 60-70. Its Flesch-Kincaid Grade
Level was 5.9 indicating that it can be understood by the
average 11 to 12 year-old.
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The research team deleted five items and amalgamated
two items on the basis of item analysis and conceptual
discussion, as well as making some final wording changes.
Items 10 and 23 were removed because they were very
highly correlated with another variable (rho>0.7) and
were highly correlated (rho>0.5) with a further three
variables. No other variables had this degree of inter-
correlation. Items 22 and 32 were deleted because fewer
than 10% of respondents rated the issue as a major bar-
rier. Three other items (12, 17, 28, and 31) also met this
criterion but were retained, the first two because they
were relatively highly endorsed by non-White partici-
pants; the third because the literature suggests that
informal care seeking is a common factor in delay in
seeking professional care [57] and perhaps would be
more evident in less unwell populations; and the fourth be-
cause concern about stigma from friends has been shown
to be an important factor in young populations [22]. Item
3 which did not meet the moderate test-retest reliability
criterion was considered for removal but retained as its re-
liability level was ‘fair’ [51] and because it was a relatively
highly rated barrier (ranked 12/36). Two stigma-related
items (9 and 26) were amalgamated with each other be-
cause only 11% rated the latter as a major barrier and
because it had some conceptual similarity to the former.
Item 36 was removed because it was considered to have
a large conceptual overlap with item 25. Thus the BACE
v3 has 30 items including 12 that are stigma-related.
Following team discussion conceptual rewording was
made to items 9, 29, 31 and 33 and minor rewording
made to item 10. When asked for free text comments on
the BACE, several respondents pointed out the need to
have a ‘not applicable box’. These have now been added
to the items referring to employment and to children.
The scoring for the treatment stigma subscale was con-
sequently amended from the mean rating to the mean of
ratings for applicable items. This scoring method has
been used successfully for other measures with varying
numbers of applicable life domains, such as the DISC
[58]. This finalised version of the BACE can be seen in
Additional file 1.
Prevalence of stigma-related and non-stigma-related
barriers to access to care
The prevalence of stigma-related and non-stigma-related
barriers to care-seeking for mental ill health reported by
this sample is shown in Table 2. The top two barriers –
‘concern that it might harm my chances when applying
for jobs’ (item 6) and ‘concern that I might be seen as a
bad parent’ (item 16) - were both stigma-related with
39% and 38% reporting these as major barriers respectively
and 89% and 88% experiencing them to some degree. The
next most highly ranked barriers were difficulty taking
time off work, being too unwell to ask for help, having had
previous bad experiences, wanting to solve the problem on
one’s own, and not wanting a mental health problem on
Table 1 Participant sociodemographic and clinical
characteristics
Variable N %
Gender (n=117) Male 24 20.5
Female 93 79.5
Ethnicity (n=117) White British 102 87.2
White Irish 5 4.3
Other white background 5 4.3
Black British / Black African 2 1.8
Indian / Bangladeshi 2 1.8
White and Asian 1 0.9
Age (n=115) Mean (sd)=36.1(11.1) Range=18 - 70
Highest level of education
(n=117)
Higher education
qualification / degree
61 54.7
Vocational qualification 16 13.7
A levels 17 14.5
GCSE / O level / CSE 19 16.2
No formal qualifications 1 0.9
Employment status
(n=117)
Work full-time 33 28.2
Work part-time 16 13.7
Volunteer 19 16.2
Looking after own children 2 1.7
Student 11 9.4
Retired 1 0.9
Not working 35 30.0
Relationship status
(n=116)
Single 52 44.8
Married / civil partnership /
cohabiting
46 39.7
Divorced or separated 16 13.8
Widowed 2 1.7
Any children (including adult
and non-resident children)
(n=116)
Yes 34 29.3
No 82 70.7
Self-reported diagnosis
(if more than one, first listed)
n=107)
Schizophrenia /
schizoaffective
disorder
5 4.7
Bipolar disorder 33 30.8
Depression 36 33.6
Anxiety disorder 13 12.1
Personality disorder 17 15.9
Other 3 2.8
Ever admitted to hospital
for psychiatric treatment?
(n=116)
Yes 53 45.7
No 63 54.3
Any involuntary
hospital admissions?
(n=114)
Yes 12 10.5
No 102 87.2
Years since first treatment
for mental health problem
(n=104)
Mean(sd)=12.9 (9.4) Range=1 - 52
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Item
no.
Barrier Barrier
type
b
Mean
(sd)
%
reporting
barrier to
any
degree
%
reporting
as major
barrier
(‘a lot’)
Rank
(1=item
has highest
proportion
rating as a
major
barrier)
1. Being unsure where to go to get
professional care
N-S 1.47
(1.05)
77.8 19.7 21
2. Wanting to solve the problem on my own N-S 1.84
(1.02)
88.0 32.5 6
3. Concern that I might be seen as weak for
having a mental health problem
S 1.75
(0.99)
86.3 25.6 12
4. Difficulty taking time off work N-S 1.75
(1.14)
78.6 34.2 3
5. Fear of being put in hospital against my will N-S 1.44
(1.08)
75.2 20.5 19
6. Concern that it might harm my chances
when applying for jobs
S 1.98
(1.01)
89.7 39.3 1
7. Problems with transport or travelling
to appointments
N-S 1.24
(1.13)
65.0 18.8 23
8. Thinking the problem would get better
by itself
N-S 1.51
(1.08)
76.9 22.2 15
9. Concern about what my family might
think or say
S 1.37
(1.10)
71.8 20.5 20
10. Being unhappy with the available services N-S 1.72
(1.05)
84.6 29.1 8
11. Feeing embarrassed or ashamed S 1.46
(1.00)
82.9 19.7 22
12. Preferring to get alternative forms of care
(e.g. spiritual care, non-Western healing /
medicine, complementary therapies)
N-S 0.49
(0.81)
33.3 4.3 35
13. Not being able to afford the financial
costs involved
N-S 1.30
(1.18)
63.2 22.2 16
14. Concern that I might be seen as ‘crazy’ S 1.38
(1.02)
78.6 16.2 25
15. Thinking that professional care probably
would not help
N-S 1.44
(1.05)
35.0 21.4 17
16. Concern that I might be seen as a bad parent
(data from parent subsample, n=34)
S 1.94
(1.04)
88.2 38.2 2
17. Professionals from my own ethnic or cultural
group not being available
N-S 0.36
(0.81)
19.7 5.1 34
18. Being too unwell to ask for help N-S 1.72
(1.11)
82.9 33.3 4
19. Concern that people I know might find out S 1.29
(1.01)
73.5 13.7 27
20. Dislike of talking about my feelings,
emotions or thoughts
N-S 1.50
(1.10)
78.6 26.5 11
21. Concern that people might not take me
seriously if they found out I was having
professional care
S 1.37
(0.98)
78.6 14.5 26
22. Having no one who could come to
appointments with me
N-S 0.90
(1.00)
53.8 9.4 31
23. Lack of trust in professionals who provide
professional care for mental health problems
N-S 1.55
(1.13)
78.6 29.1 9
24. Concerns about the treatments available
(e.g. medication side effects)
N-S 1.68
(1.00)
85.5 23.9 13
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nated stigma-related barrier. Some types of stigma-related
barriers were relatively rarely endorsed such as concern
about it bringing shame or disapproval on one’sf a m i l ya n d
about what friends might think or say with 11% and 7%
reporting these as a major barrier respectively.
Discussion
Strengths and limitations
The main strengths of the study are the iterative detailed
process of measure development and its relatively broad
assessment of psychometric properties. The key strengths
of the new measure include the comprehensiveness of
the list of potential barriers; its format making it pos-
sible to use in all care settings and with all mental health
conditions; that it encompasses care avoidance post- as
well as pre-contact with services; and its incorporation
of a barriers-based treatment stigma scale, encompass-
ing more types of stigma than existing measures. A
benefit of the measure is that it gives the flexibility to
assess the extent of a barrier (mean score), and the fre-
quency with which a barrier is experienced to any degree,
and as a major barrier. The study is limited by its self-
selected sample recruited through specific organisations,
and one of the recruitment pathways was the website
of an anti-discrimination programme (Time to Change)
which may have increased the ratings of stigma-related
barriers. The sample was also restricted to those with
internet access. Men, Black and minority ethnic groups,
and those with schizophrenia / schizoaffective disorder
diagnoses were under-represented in the sample, although
with only 42% in paid employment the sample is socioeco-
nomically diverse. The psychometric and prevalence data
may have been different had we used a sample who had
never accessed care. Because the survey software was set
up so as to require responses to all items, we have no in-
formation about the extent or patterns of missing data that
would apply with the BACE. Such data would have pro-
vided useful additional information about the acceptability
of the BACE and the content validity of its items. Our
strategy of selecting items from existing barriers measures
identified through a systematic review on stigma and
healthcare seeking may have missed some non-stigma-
related barriers, although the final measure contains 18
such items and so appears comprehensive. A further draw-
back is that, in the present study, we were not able to
undertake a full psychometric assessment, which would
include, for example, a factor analysis and examination
of responsiveness. It is a limitation that the initial selec-
tion of items was performed by one researcher rather
Table 2 Mean scores, frequencies and ranks for each barrier in the BACE v2 (n=117
a) (Continued)
25. Not wanting a mental health problem
to be on my medical records
S 1.54
(1.19)
72.6 30.8 7
26. Concern that it might bring shame or
disapproval on my family
S 0.89
(1.06)
49.6 11.1 30
27. Having had previous bad experiences with
professional care for mental health
N-S 1.56
(1.21)
72.6 33.3 5
28. Preferring to get help from family
or friends
N-S 0.58
(0.80)
41.1 2.6 36
29. Concern that my children may be taken into
care or that I may lose access or custody
(parent subsample, n=34)
S 1.41
(1.18)
67.6 23.5 14
30. Thinking I did not have a problem N-S 1.15
(1.07)
66.7 17.1 24
31. Concern about what my friends might think
or say
S 0.92
(0.95)
58.1 6.8 33
32. Thinking appointments take too much time
or are inconvenient
N-S 0.81
(0.97)
50.4 8.5 32
33. Concern that it might harm my career or
chances of promotion
S 168 (1.06) 82.1 27.4 10
34. Having problems with childcare while
I receive professional care
(parent subsample, n=34)
N-S 0.90
(1.11)
47.1 11.6 29
35. Having no one who could help me get
professional care
N-S 1.03
(1.04)
60.7 12.8 28
36. Concerns about the confidentiality of the
information I share
N-S 1.24
(1.18)
61.5 21.4 18
a. Except where otherwise stated.
b. stigma-related (S); non-stigma-related (N-S).
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applicable life domains will have a greater opportunity
to experience stigma and this could affect their treat-
ment stigma score, although the use of the mean-of-
applicable-items scoring method is likely to minimise
any such effects.
Applications
The BACE may be used to identify key barriers to care
experienced by people who currently use, or have re-
cently used, secondary mental health services, and it has
potential utility for use with general population samples.
This may help to identify potential interventions to in-
crease care seeking and service use and reduce the dur-
ation of untreated illness. It might also be used to assess
change in barriers to care after the introduction of such
interventions. The 12-item treatment stigma subscale may
be used on its own, or as part of the 30-item BACE scale
depending on the requirements of the particular research
questions being addressed. The BACE v3 is the version
recommended for use and is available, together with the
BACE manual, from the authors.
Implications for future research
Further data is needed on the performance of the BACE
v3 in a more representative sample, and one that is large
enough for factor analysis. Our group is currently
undertaking such work in the MIRIAD study (part of
the SAPPHIRE Research Programme on Stigma and
Discrimination in Mental Health, www.sapphire.iop.kcl.
ac.uk). This study will also inform us about the psycho-
metrics of the two additional items suggested by the
participants of the present study (‘Having asked for help
but not receiving it’ and ‘Having asked for help but hav-
ing to wait a long time before receiving it’) and about
two ethnicity-related barriers added because of that
study’s particular focus (‘Concern that mental health
staff will not understand cultural issues that are import-
ant to me’ and ‘Concern that I will be treated unfairly
by mental health staff or services because of my ethnic
background’). With severe mental illness, family mem-
bers often play a major role in health care-seeking on
behalf of the person affected [59]. In the MIRIAD study
we are using an adapted version of the BACE scale with
informal caregivers and will report psychometric find-
ings on the reliability and validity of this adaptation
when data collection is complete. Further psychometric
analysis is warranted to establish the responsiveness of
the BACE and its treatment stigma subscale; and to ex-
plore the factor structure of the latter. There is a need
for evidence about the scale’s performance in a commu-
nity sample. As the participants in our study had accessed
mental health care the level of barriers they reported is
likely to be lower than that of those with mental health
needs who have not accessed care, and the pattern of this
latter group may be different. Further research is needed
to elucidate levels and patterns of barriers in such popula-
tions. Lastly, the BACE is currently being used in the UK,
with planned usage in Switzerland and Nepal, however,
further evidence about its suitability for other international
contexts would be welcome.
Conclusions
We have developed a new measure of barriers to access
to care for mental ill health - the BACE – and have
demonstrated preliminary evidence of its reliability, val-
idity and acceptability. It was developed by systematically
reducing 172 barrier items identified the extant literature
to 38 (v1), then 36 (v2), then 30 (v3) to create a compre-
hensive self-complete measure assessing barriers to access
to mental health care. Through this process we identified a
broad spectrum of stigma-related barriers encompassing
anticipated discrimination, social stigma, disclosure con-
cerns, stereotypes, internalised stigma and stigma by asso-
ciation. The new measure incorporates a treatment stigma
subscale for assessing the stigma associated with receiving
mental health care. The BACE scale and its treatment
stigma subscale were found to have good test-retest reliabil-
ity, internal consistency, and content and construct validity.
The measure was positively evaluated by participants and
had readability levels appropriate for populations with men-
tal illness. The study also provided preliminary evidence
about the prevalence of stigma-related and non-stigma-
related barriers to care-seeking for mental ill health reported
by a sample of adults recently or currently using secondary
mental health services. The most frequently endorsed bar-
riers were of both types, although the top two were stigma-
related. This attests to the importance of stigma as a key
factor limiting access to mental health care [11-14,60].
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